Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04XZE
|
|||
Former ID |
DNC001582
|
|||
Drug Name |
NS-7
|
|||
Synonyms |
(3r)-3-Cyclopentyl-6-Methyl-7-[(4-Methylpiperazin-1-Yl)sulfonyl]-3,4-Dihydro-2h-1,2-Benzothiazine 1,1-Dioxide; DB08305; NS7
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Nerve injury [ICD-11: ND56.4; ICD-10: T14.4] | Phase 2 | [1] | |
Therapeutic Class |
Analgesics
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C21H29ClFN3O
|
|||
Canonical SMILES |
CC1=NC(=CC(=N1)OCCCCCN2CCCCC2)C3=CC=C(C=C3)F.Cl
|
|||
InChI |
1S/C21H28FN3O.ClH/c1-17-23-20(18-8-10-19(22)11-9-18)16-21(24-17)26-15-7-3-6-14-25-12-4-2-5-13-25;/h8-11,16H,2-7,12-15H2,1H3;1H
|
|||
InChIKey |
VLYZLIWXMLUPLD-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 178429-67-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sodium channel unspecific (NaC) | Target Info | Modulator | [1] |
KEGG Pathway | Dopaminergic synapse | |||
Reactome | Interaction between L1 and Ankyrins |
References | Top | |||
---|---|---|---|---|
REF 1 | Preferential inhibition by a novel Na(+)/Ca(2+) channel blocker NS-7 of severe to mild hypoxic injury in rat cerebrocortical slices: A possible involvement of a highly voltage-dependent blockade of Ca(2+) channel. J Pharmacol Exp Ther. 2000 May;293(2):522-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.